fierce health semaglutide The FDA has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing Novo Nordisk Escalates Fight Against

Abstract Oral pigmented lesions range from benign solitary lesions to malignant aggressive tumours

Sloop KW

doi: 10.3389/fmed.2021.689042 Received 31 March 2021 Accepted 15 June 2021 Published 09 August 2021 Volume 8 - 2021 Edited by Oscar Escribano, Complutense University of Madrid, Spain Reviewed by Adriaan Holleboom, Academic Medical Center, Netherlands

doi: 10.1210/jcem.81.1.8550773 46 BornerTWorkingerJLTinsleyICFortinSMSteinLMChepurnyOGet al

To assure optimum performance, a wet-on-wet application is recommended

Unlike pharmacological interventions that target single receptors or pathways, GHK-Cus multi-gene modulation touches many of the hallmarks of aging simultaneously: Genomic instability (DNA repair gene upregulation) Epigenetic alterations (chromatin remodeling via altered transcription factor activity) Loss of proteostasis (chaperone and proteasome pathway modulation) Cellular senescence (anti-apoptotic and anti-senescence gene networks) Altered intercellular communication (anti-inflammatory cytokine modulation) This positions GHK-Cu within what researchers increasingly call multi-hallmark peptide therapy a conceptual framework that prioritizes compounds acting across multiple aging mechanisms simultaneously